Investigating the relationship between lipid markers and diseases using advanced statistical methods.
A summary-data-based Mendelian randomization method with application to correlated lipidomic data
This study is looking at how certain fats in our bodies are linked to heart disease and diabetes, with the goal of finding better ways to prevent and treat these conditions, which could help patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10709485 on NIH RePORTER |
What this research studies
This research focuses on developing a new statistical method to analyze complex biological data related to lipids and their connection to diseases like coronary heart disease and diabetes. By utilizing advanced techniques, the researchers aim to understand how different lipid markers can influence health outcomes. Patients may benefit from this research as it seeks to uncover causal relationships that could lead to better prevention and treatment strategies for related conditions. The study will also provide tools for the broader research community to further explore these connections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of coronary heart disease or diabetes, particularly those with lipid profile abnormalities.
Not a fit: Patients without any cardiovascular or metabolic conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of conditions like coronary heart disease and diabetes.
How similar studies have performed: Previous research has shown promise in using similar statistical methods to analyze -omics data, indicating potential for success in this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ding, Ming — Univ of North Carolina Chapel Hill
- Study coordinator: Ding, Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.